Insights

Optimism and Urgency at Gates Foundation’s Malaria Forum

October 27, 2011

Largely an afterthought in most parts of the world, malaria still claims nearly one million victims each year – most of them children. IV CEO and co-founder Nathan Myhrvold joined a panel of experts at the Bill & Melinda Gates Foundation’s Malaria Forum last week to discuss the role epidemiological modeling can play in understanding and controlling this deadly disease. IV’s modeling work was also featured in Bill Gates’ keynote as one tool in the path forward toward malaria eradication. 

From updates on a promising new vaccine to a recent report that showed malaria deaths on the decline, the forum offered ample reason for optimism. But one message was clear – innovation, urgency and perseverance are needed now more than ever to make malaria a thing of the past. We’re honored to be a part of this effort and were inspired by the brilliant people we met at the forum working on this important issue.

It was at the first Malaria Forum four years ago that IV was inspired to support malaria eradication with its unique expertise in invention. Since that time, we’ve raised more than a million mosquitoes to study methods for preventing the transmission of malaria, built one of the most sophisticated disease models in the world to improve eradication campaigns, and introduced a promising new technique for detecting the disease. We’ve also expanded our work beyond malaria with a device that could strengthen vaccination services in the developing world. 

Science takes time and our work is just beginning, but we’re driven each day by the simple fact that invention saves lives. We’ll have more news about our work on this front in the coming year. In the meantime, we encourage inventors everywhere to consider how modern technology and old fashion ingenuity can improve the lives of others throughout the world.

More Buzz From IV

Bloomberg Businessweek’s “Hello World” Meets Nathan Myhrvold

Nathan Myhrvold is the subject of the latest "Hello World" episode.

Read More
IV Announces New Licensing Agreement to its Invention Investment Fund Portfolio

IIF off to a strong start in 2023.

Read More
Advancing Diversity, Equity, and Inclusion at IV

Learn more about DEI at IV and meet the council.

Read More
We use cookies on this website to enhance your browser experience and to analyze your traffic. To learn more about cookies and how we use them view our cookie policy. By continuing to use our website you consent to the use of cookies.